Get informed when a big investor buys or sells
+ FollowLoading insider trades…
Loading congress trades…
| Market cap | $103.66 Million |
|---|---|
| Enterprise Value | $102.33 Million |
| Earnings per Share | $-3.22 |
| Beta | 0.72 |
| Outstanding Shares | - |
| P/E Ratio | -5.77 |
|---|---|
| PEG | -939.35 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 10.96 |
| Enterprise Value to EBIT | -7.88 |
| Enterprise Value to Net Income | -5 |
| Total Debt to Enterprise | 0.08 |
| Debt to Equity | -1.84 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Adocia S.A. is a clinical-stage biotechnology firm that specializes in developing enhanced formulations of existing therapeutic proteins and peptides, primarily targeting diabetes and other metabolic disorders. The company leverages its ...